碘-131抗B1抗体疗法治疗非霍奇金淋巴瘤：剂量测定及临床意义 - Suppr | 超能文献

Iodine-131 anti-B1 antibody therapy in non-Hodgkin's lymphoma: dosimetry and clinical implications.

作者信息

Wahl R L

机构信息

University of Michigan Medical Center, Ann Arbor 48109-0028, USA.

出版信息

J Nucl Med. 1998 Aug;39(8 Suppl):1S.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Iodine-131 anti-B1 antibody therapy in non-Hodgkin's lymphoma: dosimetry and clinical implications.碘-131抗B1抗体疗法治疗非霍奇金淋巴瘤：剂量测定及临床意义

J Nucl Med. 1998 Aug;39(8 Suppl):1S.

2

[Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].[非霍奇金淋巴瘤的放射免疫疗法。重点关注抗CD20治疗]

Ugeskr Laeger. 2005 Oct 10;167(41):3867-9.

3

Revised Nuclear Regulatory Commission regulations for release of patients administered radioactive materials: outpatient iodine-131 anti-B1 therapy.美国核管理委员会关于接受放射性物质治疗患者出院的修订规定：门诊碘-131抗B1治疗

J Nucl Med. 1998 Aug;39(8 Suppl):28S-33S.

4

Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody.90Y标记的抗CD20单克隆抗体用于非霍奇金淋巴瘤放射免疫治疗的给药指南。

J Nucl Med. 2003 May;44(5):853.

5

Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.放射性金属标记抗体是否优于碘-131标记抗体：非霍奇金淋巴瘤患者中铜-67、碘-131和钇-90标记的Lym-1抗体的比较药代动力学和剂量学研究

Clin Lymphoma. 2000 Sep;1(2):118-26. doi: 10.3816/clm.2000.n.010.

6

Radioimmunotherapy of Non-Hodgkin's lymphoma.非霍奇金淋巴瘤的放射免疫疗法

J Nucl Med. 2004 May;45(5):924-5.

7

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy.托西莫单抗和（131）I-托西莫单抗治疗后患者出院的实用方法。

J Nucl Med. 2002 Mar;43(3):354-63.

8

Radioimmunotherapy of non-Hodgkin's lymphoma revisited.非霍奇金淋巴瘤的放射免疫治疗再探讨。

J Nucl Med. 2005 Feb;46(2):383-4.

9

Centralized radiolabeling of antibodies for radioimmunotherapy.用于放射免疫治疗的抗体集中放射性标记

J Nucl Med. 1998 Aug;39(8 Suppl):11S-13S.

10

Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.131I-抗B1抗体治疗初治淋巴瘤患者的杂交单光子发射计算机断层扫描——共轭视图肿瘤剂量测定的初步结果

J Nucl Med. 2000 Sep;41(9):1579-86.

引用本文的文献

1

Radiopharmaceutical therapy in cancer: clinical advances and challenges.放射性药物治疗癌症：临床进展与挑战。

Nat Rev Drug Discov. 2020 Sep;19(9):589-608. doi: 10.1038/s41573-020-0073-9. Epub 2020 Jul 29.

2

Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in (131)I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma.通过SPECT/CT多模态成像对非霍奇金淋巴瘤的（131）I-抗CD20利妥昔单抗放射免疫治疗进行前瞻性全身骨髓剂量测定的验证

Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):458-69. doi: 10.1007/s00259-004-1692-9. Epub 2004 Nov 20.